Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-020-00892-9
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2020
Authors
Publisher
Springer Science and Business Media LLC